news

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial…

10 months ago

InnovAge Florida PACE Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leader in senior care through…

10 months ago

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage…

10 months ago

Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements

Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software…

10 months ago

Smart Share Global Limited Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company from Hillhouse

August 15, 2025 16:15 ET  | Source: Smart Share Global Limited SHANGHAI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Smart Share…

10 months ago

Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results

NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the…

10 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

10 months ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in…

10 months ago

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)

August 15, 2025 16:05 ET  | Source: X4 Pharmaceuticals BOSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a…

10 months ago

Automobili Lamborghini Unveils Fenomeno, a New Limited Production Masterpiece at The Quail, A Motorsports Gathering

Produced in just 29 units, the Fenomeno is the most powerful V12 model Lamborghini has ever createdSant’Agata Bolognese/Carmel-By-The-Sea, 16 August…

10 months ago